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Abstract
Background: Neonatal hypoxia-ischemia induces massive brain damage during the perinatal period, resulting in
long-term consequences to central nervous system structural and functional maturation. Although neural
progenitor cells (NPCs) migrate through the parenchyma and home in to injury sites in the rodent brain, the
molecular mechanisms are unknown. We examined the role of chemokines in mediating NPC migration after
neonatal hypoxic-ischemic brain injury.
Methods: Nine-day-old mice were exposed to a 120-minute hypoxia following unilateral carotid occlusion.
Chemokine levels were quantified in mouse brain extract. Migration and proliferation assays were performed using
embryonic and infant mouse NPCs.
Results: The neonatal hypoxic-ischemic brain injury resulted in an ipsilateral lesion, which was extended to the
cortical and striatal areas. NPCs migrated toward an injured area, where a marked increase of CC chemokines was
detected. In vitro studies showed that incubation of NPCs with recombinant mouse CCL11 promoted migration
and proliferation. These effects were partly inhibited by a CCR3 antagonist, SB297006.
Conclusions: Our data implicate an important effect of CCL11 for mouse NPCs. The effective activation of NPCs
may offer a promising strategy for neuroregeneration in neonatal hypoxic-ischemic brain injury.
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Background
Perinatal hypoxia and ischemia can cause serious com-
plications. In neonatal animal models, accumulating
evidence suggests that hypoxic-ischemic brain damage
influences the activation of endogenous neural progeni-
tor cells (NPCs) in the subventricular zone (SVZ) [1].
Increased neurogenesis and migration of NPCs toward
the injury site has been observed in animal models of
epilepsy, stroke, trauma, Alzheimer’s disease, Parkinson’s
disease, and Huntington’s disease [2]. Recent studies in-
dicate that neurogenesis may play regenerative roles in
response to central nervous system (CNS) injuries.
Neurogenesis in the immature mammalian brain is
highly modulated by excitotoxic insults [3, 4]. Moreover,
NPCs have been shown to be induced in the post-stroke
human cerebral cortex for more than 1 month based on
immunostaining of autopsied tissue from stroke patients
[5, 6]. Although the origin of these NPCs is uncertain,
this raises the possibility of developing therapeutic
strategies aimed at activating the neurogenic capacity in
order to repair the damaged brain.
Nevertheless, the molecular mechanisms for NPC
activation and mobilization have not been clearly identi-
fied. It has been demonstrated in rodents that repulsive
Slit-Robo signal orientated the migration of newly gener-
ated immature neurons through the rostral migratory
stream (RMS) under normal conditions. RMS astrocytes
express Robo receptors and regulate the rapid migration
of Slit1-expressing new neurons [7]. Fibroblast growth
factor 2 (FGF-2) and anosmin-1 increase SVZ NPC
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migration via epidermal growth factor receptor 1
(EGFR1) during pre- and postnatal rat development [8].
In contrast, in the injured brain, NPCs from the SVZ
migrate to injury sites through blood vessels for up to
1 year after injury [9, 10]. This directed NPC migration
is considered the result of chemoattractive cues
expressed from the injury site. Inflammatory mediators
contribute to the pathological changes, which are sensi-
tive to hypoxic-ischemic brain injury [11].
We hypothesized that inflammatory mediators were
involved in the migration of NPCs toward the injury site.
The major role of chemokines is to act as a chemo-
attractant to guide the migration of immune cells. The
CC chemokines induce recruitment of eosinophils, baso-
phils, neutrophils, and monocytes, and play important
roles in the regulation of many inflammatory conditions.
In this study, we demonstrated that CCL11, one of CC
chemokines highly expressed at brain injury sites, pro-
moted the migration and proliferation of NPCs. These
findings suggest that CCL11 may have important
functions in the neonatal CNS.
Methods
In vivo study
Neonatal ischemia-reperfusion brain injury
The NOD/SCID (NOD.CB17-Prkdcscid/J) mice were
purchased from Charles River Laboratories Japan Inc.
(Kanagawa, Japan). Experimental mouse models of neo-
natal ischemia-reperfusion brain injury were used based
on a modified Rice-Vannucci model as previously de-
scribed [12]. Briefly, 9-day-old postnatal NOD/SCID
mice of both sexes (n = 48) were anesthetized with 2%
isoflurane. The right common carotid artery (CCA) was
occluded with an aneurysm clip (Mizuho, Tokyo, Japan).
The pups were placed in a hypoxia chamber held at 8%
O2 for 120 minutes. Reperfusion was achieved by
unclamping the artery and exposing the pups to nor-
moxic conditions. Pups were returned to their dams
after the procedure. Sham-operated mice (n = 8) were
subjected to CCA isolation alone and no brain injury.
NOD/SCID mice aged 1, 2, 4, 6, and 8 weeks were used
as normal control (n = 30). All animal experiments were
performed under an institutionally approved protocol
for the use of animal research at Kochi University
(approval number: J-00002).
Magnetic resonance imaging
Magnetic resonance imaging (MRI) measurements were
performed on a Varian 9.4 T vertical MR system with con-
sole Vnmr interface (Agilent Technologies, Santa Clara,
CA, USA). The mice were anesthetized with 2% isoflurane
and placed in a vertical animal positioning unit. The MRI
sequence used was a T2-weighted Spin Echo Multi Slice
(SEMS) imaging sequence (T2WI) with the following
parameters: repetition time (TR), 2000 ms; echo time
(TE), 10 ms; 1 mm thick slices; number of scans, 9; field
of view (FOV), 2 × 2 cm; and matrix size, 256 × 128. The
total imaging time for each sequence was 16 minutes.
Immunohistochemistry
At each follow-up time point, the brains were removed and
fixed in 4% paraformaldehyde. Coronal brain sections
(12 μm) were prepared using a microtome (Leica Microsys-
tems Inc., Wetzlar, Germany). The primary and secondary
antibodies used in the experiments were: rabbit anti-
Doublecortin (Dcx) antibody (1:1000, Abcam, Cambridge,
UK), mouse anti-polysialylated neural cell adhesion mol-
ecule (PSA-NCAM) antibody (1:200, Merck Millipore,
Darmstadt, Germany) and Alexa Fluor® 488 and 594 goat
anti-rabbit IgG (1:1000, Thermo Fisher Scientific Waltham,
MA, USA). Slides were mounted with ProLong™ Diamond
Anti-fade Mountant with DAPI (Life Technologies,
Carlsbad, CA, USA). The slides were observed using a
fluorescence microscope (BZ-9000; Keyence, Osaka, Japan).
Dcx and PSA-NCAM-positive cells were counted per slice.
Chemokine quantification
The brain tissue of mice were collected at each follow-up
time point. The lysate was prepared by homogenization in
RIPA Lysis and Extraction Buffer (Thermo Fisher
Scientific) containing a complete protease inhibitor cock-
tail (Roche, Basel, Switzerland). The tissue debris was
removed by centrifugation at 1000 × g for 10 minutes at
4 °C. Protein concentration was determined with BCA
Protein Assay Kit (Thermo Fisher Scientific).
Chemokine levels in RIPA-extracted lysates were
quantified using CCL9 ELISA Kit (Sigma-Aldrich, St.
Louis, MO, USA), CCL12 Quantikine ELISA Kit (R&D
Systems, Minneapolis, MN, USA), and LEGENDplex
Multi-Analyte Flow Assay Kit for Mouse Proinflamma-
tory Chemokine (BioLegend, San Diego, CA, USA)
according to the manufacturer’s instructions. Data were
normalized to the expression level in the 1 mg/ml of
total protein of the lysates. The relative detection thresh-
old of those assays was 0.2 pg/ml except the CCL12
assay, which was 1.5 pg/ml.
Neutralizing assay
A neutralizing rat monoclonal CCL11 antibody (R&D
Systems) at a dose of 25 μg/mouse was administrated
twice at 6 and 24 hours after brain injury. At 1 week
after injury, the brains were removed and fixed in 4%
paraformaldehyde. The primary and secondary anti-
bodies used in the experiments were: rabbit anti-Dcx
antibody (1:1000, Abcam) and Alexa Fluor™ 488 goat
anti-rabbit IgG (1:1000, Thermo Fisher Scientific). The
slides were observed using a fluorescence microscope
(BZ-9000; Keyence).
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In vitro study
Isolation and culture neural stem/progenitor cells
Embryonic NPCs were isolated from pregnant NOD/SCID
mice (n = 3) on E13.5 day of gestation. Striata were dis-
sected from each embryo in phosphate-buffered saline
(PBS) containing 0.6% glucose (Sigma-Aldrich) and
penicillin-streptomycin (50 U/ml; Life Technologies).
After dissection, the tissue was triturated to a single cell
suspension using a transfer pipette. Cells were cultured in
NeuroCult™ Proliferation Medium containing 20 ng/ml
epidermal growth factor (EGF) (Stemcell Technologies
Inc., Vancouver, BC, Canada). NPCs from infant NOD/
SCID mice were isolated from the ipsilateral and contra-
lateral SVZ at 1 week post-injury (n = 5). The SVZ tissue
was triturated with neural tissue dissociation solution
(Sumitomo Dainippon Pharma Co., Ltd, Tokyo, Japan).
Cells were cultured in NeuroCult™ Proliferation Medium
containing 20 ng/ml EGF, 10 ng/ml fibroblast growth fac-
tor (FGF) and 2 μl/ml heparin (Stemcell Technologies
Inc.). Cells were proliferated to generate neurospheres.
RT-PCR
Total RNA was isolated from neurospheres using an
RNeasy Mini kit (Qiagen, Hilden, Germany) according
to the manufacturer’s instruction. RT-PCR was per-
formed using PrimeScript RT reagent kit (Takara Bio
Inc., Otsu, Japan) for reverse transcription, and Ex Taq
(Takara Bio Inc.) for PCR amplification. Details of
primer sequences are shown in Table 1.
Flow cytometry
Expression of NPC surface markers was analyzed using
the LSR Fortessa (Becton Dickinson, San Jose, CA,
USA). NPCs were plated onto poly-D-lysine coated T-25
culture flasks. At 24 hours after seeding, NPCs were
collected and washed twice with staining buffer, and
resuspended in 100 μL of PE-conjugated anti-mouse
PSA-NCAM antibody (Miltenyi Biotec Inc., Bergisch
Gladbach, Germany, 1:11) or PE-conjugated mouse IgM
isotype control antibody (Miltenyi Biotec Inc., 1:50).
Data was evaluated using FlowJo software (Tree Star,
Inc., Ashland, OR, USA).
Migration assay
Carrier-free forms of mouse recombinant CCL2, CCL3,
CCL4, CCL5, CCL9, CCL11, CCL12, CCL20, and CCL22
were purchased from BioLegend (San Diego, CA, USA).
Assays utilized a poly-D-lysine coating μ-slide Chemotax-
is3D (ibidi GmbH, Munich, Germany). 3 × 106 cells/ml
were seeded onto the μ-slides and incubated at 37 °C. Mi-
gration was stimulated by addition of the chemokine
(20 μg/ml) dissolved in PBS to the indicated port. Time-
lapse imaging was performed using BioStation IM-Q
(Nikon, Tokyo, Japan) with a × 20 objective. Images were
captured every 15 minutes for 24 hours. Twelve cells were
randomly chosen in each chemokine assay for data ana-
lysis. The migration trajectory and distance were mea-
sured with ImageJ using the Manual Tracking plugin for
NIH ImageJ software (Bethesda, MD, USA).
Cell culture assay
Embryonic and infant NPCs were plated onto 96-well
plates at a cell density of 1 × 104 cells/well. Each chemo-
kine (2 μg/ml) was added to cell cultures. The culture
medium used was NeuroCult™ Proliferation Medium
without EGF, FGF, and heparin. After 1 and 3 days of
culture, 10 μl of CCK-8 (Dojindo, Kumamoto, Japan) so-
lution was added in triplicate to wells, and incubated for
2 hours at 37 °C. Absorbance at 450 nm was then mea-
sured in a microplate reader (Thermo Fisher Scientific).
Immunocytochemistry
NPCs were fixed with 4% paraformaldehyde before mi-
gration assay. After fixation, mouse anti-Dcx antibody
(1:250) and rabbit anti-CCR3 antibody (1:250, Abcam)
were applied at 4 °C overnight. Alexa Fluor™ 488-
conjugated anti-mouse IgG (1:500) and Alexa Fluor™
594-conjugated anti-rabbit IgG (1:500, Thermo Fisher
Scientific) were used as the respective secondary anti-
body. The cells were observed using a fluorescence
microscope (BZ-9000; Keyence).
CCR3 blocking assay
To evaluate CCR3 blocking, NPCs were incubated with
the CCR3 antagonist SB 297006 (100 μM) for 30 minutes
and then stimulated with CCL11 (2 μg/ml). After 3 days
of culture, NPCs were subjected to CCK-8 assays.
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Statistical analysis
The data are presented as means ± S.D. Results from dif-
ferent groups were compared using the Student’s t test,
or one-way ANOVA followed by Dunnett’s multiple
comparison tests. P < 0.05 was considered to indicate a
statistically significant difference.
Results
NPCs migration in the mouse brain
The experimental design is showed in Fig. 1a. The
mouse model of neonatal ischemia-reperfusion injury
was induced at post-natal day 9. MRI was performed
1 week after the brain injury. T2 hyperintensity
abnormalities reflecting tissue edema were observed
in the cortex and striatum of the mouse brain
(Fig. 1b). We evaluated the migration of NPCs (Dcx-
positive cells) in the neonatal mice brain (Fig. 1c). In
the injured SVZ side, the number of Dcx-positive
cells began to increase rapidly at 1 week, and was
stable thereafter for up to 7 weeks following the brain
injury (Fig. 1c, f ). At 5 weeks post-injury, Dcx-posi-
tive cells had migrated a long distance and had
reached the core injury area (Fig. 1d). In contrast, in
the intact SVZ side, the number of Dcx-positive cells
was diminished with advancing age (Fig. 1e). The
number of PSA-NCAM-positive cells was also signifi-
cantly increased in the injured side (Additional file 2:
Figure S2a, b). In the sham-operated mice, there was
no difference in the number of Dcx-positive cells
between the intact side and the injury side
(Additional file 2: Figure S2c, d).
Chemokine expression in the mouse brain
Chemokine levels were quantified using ELISA Kit and
Multi-Analyte Flow Assay Kit for Mouse Proinflammatory
Chemokine. We focused on the expression profile of nine
Fig. 1 The proliferation and migration of Dcx-positive cells in a mouse model of neonatal ischemia-reperfusion brain injury. a The timeline of the
study design. b Serial coronal T2-weighted MR images at 1 week after brain injury. T2 hyperintensity abnormalities were observed in the cortex
and striatum. Five coronal slices were acquired with 1 mm thickness. c Fluorescent image of the ipsilateral (injury) and contralateral (intact) side
of SVZ in the model mouse. In the injured SVZ side, the number of Dcx-positive cells began to increase rapidly at 1 week, and was stable thereafter for
up to 7 weeks following the injury. Green: Dcx; blue: DAPI. Scale bar = 50 μm. LV lateral ventricle. d Dcx-positive cells were migrated to the injured site
at 5 weeks post-injury. Green: Dcx. Scale bar = 200 μm. e In the intact SVZ side, the number of Dcx-positive cells was diminished with advancing age.
N = 5 for each time point. The data are presented as the mean numbers of positive cells in the SVZ ± S.D. *P < 0.05. f Number of Dcx-positive cells per
slice in 1–7 weeks post-injury. Abundant Dcx-positive cells were distributed from the SVZ laterally toward the damaged area. N = 6 for each time point.
The data are presented as the mean numbers of positive cells in the ischemic hemisphere (injury side), and the contralateral hemisphere (intact side)
± S.D. *P < 0.05, **P < 0.01
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CC chemokines upregulated in the injured mouse brain:
CCL2, CCL3, CCL4, CCL5, CCL9, CCL11, CCL12,
CCL20, and CCL22. At 24 hours post-injury, most chemo-
kines were highly expressed even in the intact side of the
injured brain compared with the undamaged brain
(CNT). At 1 week post-injury, CCL2, CCL3, CCL4, CCL5,
CCL11, CCL12, CCL20, and CCL22 were significantly up-
regulated in the injury side, although there was little dif-
ference between the injury and intact side in most
chemokines at 3 weeks post-injury. Only CCL9 expression
was maintained at high levels in both sides of brain up to
3 weeks post-injury (Fig. 2).
In vitro migration assay
Neurospheres were generated from the embryo and in-
fant mice brains, and these showed high expression of
sex-determining region Y-box 2 (SOX2), Ki-67, and no
expression of the mature neuronal marker, NeuN
(Fig. 3a). NPCs cultured on poly-D-lysine expressed the
neuroblast maker, PSA-NCAM (PSA-NCAM+ cells:
68.7 ± 5.2%, PSA-NCAM- cells: 30.2 ± 2.9%) and Dcx
(Fig. 3b, c). We then evaluated the effect of chemokines
on NPC migration. Cell tracking with CCL11 over
24 hours of monitoring is shown in Fig. 3d. The minus
(leftward) direction of cell movement was defined as
Fig. 2 Chemokine quantification. Nine CC chemokines were quantified in the brain tissue extract. In the injury side, most chemokines were
significantly upregulated at 24 hours post-injury compared with the intact side. Samples prepared from healthy (non-manipulated) mice were
used as control (CNT). N = 4 for each time point. The data are presented as the mean of chemokine secretion in the ischemic hemisphere (injury
side), and the contralateral hemisphere (intact side) ± S.E.M. *P < 0.05, **P < 0.01, ***P < 0.005. N.D. not detected
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Fig. 3 (See legend on next page.)
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chemokine-induced migration (Fig. 3e). Each color rep-
resents the trajectory of an individual cell. NPCs actively
proliferated and migrated toward the CCL11 injected
side (Fig. 3e, Additional file 1: Figure S1). When migration
distance and end points of embryonic NPCs between each
chemokine were compared, CCL11 significantly promoted
embryonic NPCs migration compared with PBS or other
chemokines (Fig. 3g, PBS: -0.77 ± 4.3 μm; CCL11: -65.9 ±
11.6 μm). Although CCL11 also promoted migration of
NPCs derived from the brain-injured infant mice, the end
points of migration were decreased in the infant NPCs
compared to embryonic NPCs. There was no significant
difference between the injury side and intact side of NPCs
from infant brain (Fig. 3f, h).
Cell culture assay
Proliferation of embryonic NPCs was enhanced after in-
cubation with recombinant mouse CCL11 (Fig. 4a).
Moreover, the proliferative effect of CCL11 was
concentration-dependent. Only NPCs incubated with
(See figure on previous page.)
Fig. 3 Isolation of NPCs and migration assay. a The neurosphere from embryonic and infant mouse brains. Genes involved in proliferation and
multipotency were expressed in cultured NPCs. Scale bar = 50 μm. b Flow-cytometric analysis for NPCs. The left panel showed an isotype control
mouse IgM antibody. The right panel showed that PSA-NCAM was expressed in NPCs. c Immunostaining of Dcx for embryonic NPCs. Dcx-positive
cells showed spindle cell morphology. Green: Dcx; blue: DAPI. Scale bar = 30 μm. d Migration assay using μ-Slide Chemotaxis. NPCs were seeded
at 3 × 106 cells/ml in the shaded area. Chemokine was injected through the indicated port. Time-lapse imaging and tracking of NPCs with CCL11
(blue line). Scale bar = 100 μm. e, f The trajectory of randomly selected embryonic (e) and infant (f) NPCs in migration assay. Each color represents
the trajectory of an individual cell. The y-axis and the x-axis represents migration distance (μm). The minus (leftward) direction of cell movement
is defined as chemokine-induced migration. g The distance and end point of embryonic NPCs migration. CCL11 significantly increased the
migration distance of NPCs compared with the control (PBS) and other chemokines. The data are presented as the mean of end points ± S.D. The
migration assay was repeated three independent times per chemokine. *P < 0.05, **P < 0.01. h The end point of trajectory of the embryonic NPCs
(E-NPC) and infant NPCs (I-NPC) derived from the injury and intact side of mouse brain using CCL11. *P < 0.05. n.s. not significant
Fig. 4 The cell culture assay for NPCs. a Proliferation of embryonic NPCs was enhanced after incubation with 2 μg/ml CCL11 at 3 days post-treatment.
Other CC chemokines neither formed the neurospheres nor enhanced NSC proliferation. The data are presented as the mean absorbance of three
replicates ± S.D. **P < 0.01. b The concentration-dependent effect of CCL11 on NPC proliferation. High concentration of CCL11 (2 μg/ml, 5 μg/ml)
promoted NPC proliferation. **P < 0.01 vs control (PBS). c NPCs treated with 2 μg/ml CCL11 formed neurospheres at 3 days post-treatment. Scale
bar = 50 μm. d CCL11 (2 μg/ml) enhanced proliferation of infant NPCs derived from both injury and intact sides of the mouse brain. The data are
presented as the mean absorbance of three replicates ± S.D. *P < 0.05. e, f The CCR3 receptor antagonist SB 297006 blocked the CCL11-induced NPC
proliferation and neurosphere formation. Scale bar = 50 μm. *P < 0.05, **P < 0.01. g Merged image of double immunostaining of Dcx and CCR3 for
embryonic NPCs. Green: Dcx; red: CCR3, blue: DAPI. Scale bar = 30 μm. h RT-PCR analysis of CCR3 expression in NPCs. CCR3 are expressed in embryonic
and infant NPCs
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CCL11 formed neurospheres, and other CC chemokines
neither induced neurosphere formation nor enhanced
NPC proliferation (Fig. 4b, c). CCL11 also enhanced the
proliferation of infant NPCs. There was no significant
difference in proliferation activity between NPCs derived
from the injury side and those from the intact side of
the infant mouse brain (Fig. 4d).
Receptor blocking assay
The major receptor for CCL11 is CCR3, which is found
on leukocytes [13]. We then analyzed whether chemo-
kine/receptor signaling influenced the proliferation of
NPCs. NPCs expressed a functional chemokine receptor
CCR3, and CCR3 receptor antagonist, SB297006 signifi-
cantly inhibited proliferation and neurosphere formation
in CCL11-treated NPCs (Fig. 4e-h).
In vivo neutralizing assay
A neutralizing CCL11 antibody was administrated in the
model mice at 6 and 24 hours after injury. There was no
significant difference of NPC migration and proliferation
between the antibody-treated group and the PBS-treated
group (Fig. 5a, b).
Discussion
NPCs migration and chemokines in an injured brain
A number of studies have shown activation and recruit-
ment of NPCs in animal models of ischemic brain injury
[14–16]. The number of NPCs correlated with the vol-
ume of brain injury in the mouse model of stroke [17].
While low oxygen increased the proliferation of neural
stem cells in vitro [18], oxygen glucose deprivation
(OGD) decreased the growth of NPCs and also de-
creased the phosphorylation of extracellular signal regu-
lated kinase (ERK) [19]. The hypoxic-ischemic condition
depletes the ATP content of the cells, compromising
their metabolic activity. Various inflammatory mediators
(cytokines, chemokines, and adhesion molecules) are
produced from immune cells, endothelial cells, fibroblasts,
and brain cells after ischemic injury. Directed NPC migra-
tion is considered to be the result of chemoattractive cues
expressed from the injury site. Our chemokine quantifica-
tion data demonstrated that CC chemokines were mark-
edly elevated at 24 hours after injury, and were gradually
reduced over 3 weeks post-injury in the infant mouse
brain. Peculiarly, CCL2 and CCL11 were significantly up-
regulated in the injury side compared with the intact side
up to 3 weeks post-injury. Chemokines are 8–14 kDa
small molecules mainly regulating immune cells traffick-
ing during inflammatory responses. Chemokine-mediated
signaling leads to cytoskeletal rearrangements that allow
cell polarization toward the chemokine gradient. In recent
years, chemokines have been reported to have non-
immunological effects in the CNS, including regulation of
cell proliferation, migration, survival, and synaptic activity
[20]. Adult NPCs have been shown to express chemokine
receptors, including CCR1-8, 10, and CXCR1-6 [21].
Among chemokine receptors, CXCL12/CXCR4 signaling is
important for neural progenitor cell guidance and orienta-
tion in the developing mammalian brain [22, 23]. Follow-
ing neural damage, CXCL12/CXCR4 signaling mediates
specific migration of NPCs to the ischemic damaged
site [24]. Several signaling pathways may mediate
CXCL12-induced NPC migration, including inositol
1,4,5-triphosphate, extracellular signal-regulated kinases
1/2, Akt, c-Jun N-terminal kinase, and intracellular cal-
cium [25]. CCL2, CCL3, and CXCL1 also promote NPC
migration to the striatum following quinolinic acid-
induced lesion [26]. IFN-γ and IFN-β both inhibit cultured
adult NPCs proliferation, but only IFN-γ promotes neur-
onal differentiation [27]. In the present study, CCL2 and
CCL3 were upregulated in the injury side in the hypoxic-
ischemic brain of neonatal mice. The migration assay
showed that CCL2 and CCL3 slightly promoted NPC mi-
gration. Since NPCs are placed into the gap of μ − slide
Chemotaxis3D and exposed to linear concentration
Fig. 5 The neutralizing assay in the model mice of neonatal hypoxic-ischemic brain injury. a Fluorescent image of the ipsilateral (injury) side of
SVZ in model mouse. Green: Dcx; blue: DAPI. Scale bar = 100 μm. b Number of Dcx-positive cells per slice in the model mice. N = 4. The data are
presented as the mean numbers of Dcx-positive cells in the ischemic hemisphere (injury side) ± S.D. n.s. not significant
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gradients, the concentration of chemokines in the NPC
area might be quite diluted. In consideration of a local in-
flammatory response, the induction effect may vary with
the concentration of each chemokine in the injured mouse
brain. The results of in vivo neutralizing assay suggests
that the activation and migration of NPCs seems to be
controlled by an orchestration of cytokines include inter-
leukins, interferons, growth factors and chemokines in the
brain-injured mice.
In another study, induction of striatal neurogenesis by the
intraventricular administration of brain-derived neuro-
trophic factor (BDNF) and EGF promoted functional recov-
ery in a mouse model of neonatal hypoxic-ischemic brain
injury. In contrast, this BDNF/EGF-associated functional re-
covery was abolished in mice receiving a co-infusion of 2%
cytosine-b-D-arabinofuranoside (Ara-C), a mitotic inhibitor.
These results indicate that the effect of functional recovery
may be the result of newly generated neurons [28]. Identifi-
cation of more factors responsible for recruitment of NPCs
to the injury site may lead to the development of therapies
designed to promote functional recovery after neonatal
ischemia-reperfusion brain injury.
Role of CCL11 in CNS
Whereas chemokine signaling in immune cells has been
studied in detail, the molecular mechanisms of
chemokine-induced NPC activation are not completely
understood. This study has shown that a chemokine,
CCL11, could activate NPCs in vitro. The CCL11 activity
for NPCs was exerted under EGF- and FGF-free condi-
tions. CCL11 is traditionally associated with eosinophil re-
cruitment and pro-inflammatory responses [29, 30]. The
mechanism of how CCL11 affects the brain has not been
determined. Recently, increased blood levels of CCL11 in
aging have been shown to negatively regulate adult hippo-
campal neurogenesis. Systemic CCL11 administration
decreased the numbers of Dcx-positive cells in the dentate
gyrus of young mice. Young mice that received CCL11 ex-
hibited impaired learning and memory deficits [31]. In
aged mice, plasma CCL11 protein levels were significantly
increased in 18-month-old mice than in 21-month-old
mice [32]. In the mice model of experimental cerebral
malaria, CCL11 was elevated in the hippocampus and
frontal cortex. Dcx-positive cells in the dentate gyrus were
decreased in parallel with increased CCL11 [33]. Further-
more, CCL11 promoted the migration of microglia, and in-
duced microglial production of reactive oxygen species.
CCL11 triggers oxidative stress via microglial activation
and potentiates glutamate-mediated neurotoxicity, which
may be involved in the pathogenesis of various neurological
disorders [34]. In one physiological study, the striatum had
an early rapid-uptake phase for CCL11, which was the fast-
est among different brain regions [35]. CCL11 in the circu-
lation can cross many regions of the blood-brain barrier
(BBB). This suggests that blood-borne CCL11 may have
important physiological functions in the CNS and impli-
cates the BBB as an important regulator of the physio-
logical versus pathological effects of this chemokine. Our
results may reflect opposite effects of CCL11 on NPCs, as
recently reported in previous studies. In our study, the pro-
liferation of NPCs was promoted at a much higher concen-
tration (1–5 μg/ml) of CCL11 compared to Villeda’s study
(10 ng/ml) [31]. Moreover, CCL11 might have differential
effects in SVZ NPCs compared to hippocampal NPCs.
Meanwhile, positive effects of CCL11 have also been re-
ported in several studies. Adzemovic et al. demonstrated
that the CCL11/CCR3 pathway was associated with im-
mune response modulation in a rat model of multiple
sclerosis (MS). The milder EAE phenotype in the Eae18b
congenic strain of rat was accompanied by significantly
lower myelin loss and reduced cumulative microglia activa-
tion. The congenic rats significantly upregulated CCL11
mRNA in lymph nodes and spinal cord tissue [36]. More-
over, CCL11/CCR3 promotes the proliferation of oligo-
dendrocyte precursor cells (OPCs) and migration of
smooth muscle cells (SMCs) [37, 38]. Both of these cells
are involved in the regeneration of damaged tissue. In
demyelinating diseases such as MS, remyelination is pre-
ceded by the division of endogenous NG2-positive OPCs.
The OPCs migrate to sites of injury and differentiate into
mature oligodendrocytes [39, 40]. In atherosclerosis, SMCs
proliferate and migrate to form part of the intimal plaque
[41]. Furukawa et al. showed that IL-10, an anti-
inflammatory cytokine elevation was correlated with
milder symptoms and that CCL11 elevation was correlated
with slower disease progression in patients with amyo-
trophic lateral sclerosis (ALS), suggesting that those cyto-
kines may confer neuroprotection against ALS [42].
Therefore, CCL11 may have both beneficial and harmful
effects in the CNS that depend on factors such as concen-
tration, anatomical location, and pathological condition.
Conclusions
We have investigated the mechanisms for NPC activation
in a mouse model of neonatal ischemia-reperfusion brain
injury. Our main findings are that CCL11 affects the migra-
tion and proliferation of NPCs. Further studies are needed
to delineate the regulatory pathways and downstream sig-
naling. The activation of NPCs may offer a promising strat-
egy for neuroregeneration in neonatal hypoxic-ischemic
brain injury and general neurological disorders as well.
Additional files
Additional file 1: Figure S1. The time-lapse movie of NPC migration.
Images were captured every 15 minutes for 24 hours. (A) NPCs did not migrate
toward the PBS-injected side. (B) After CCL11 injection, NPCs actively proliferated
and migrated toward the CCL11-injected side. (ZIP 144651 kb)
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Additional file 2: Figure S2. The immunostaining in the model mice of
neonatal hypoxic-ischemic brain injury and the sham-operated mice. (A)
PSA-NCAM immunostaining image of SVZ in the model mouse. Red:
PSA-NCAM; blue: DAPI. Scale bar = 50 μm. (B) Number of PSA-NCAM-
positive cells per slice. N = 8. The data are presented as the mean
numbers of PSA-NCAM-positive cells in the injury side and the intact side
± SD. *P < 0.05. (C) Dcx immunostaining image of SVZ in the sham-
operated mouse. N = 6. Green: Dcx; blue: DAPI. Scale bar = 50 μm. (D)
Number of Dcx-positive cells per slice. N = 8. The data are presented as
the mean numbers of Dcx-positive cells in the sham-operated side and
the intact side ± SD. n.s. not significant. (PDF 655 kb)
Abbreviations
ALS: Amyotrophic lateral sclerosis; BBB: Blood-brain barrier; BDNF:
Brain-derived neurotrophic factor; CCA: Common carotid artery; CNS: Central
nervous system; Dcx: Doublecortin; EGF: Epidermal growth factor;
EGFR1: Epidermal growth factor receptor 1; FGF: Fibroblast growth factor;
MRI: Magnetic resonance imaging; MS: multiple sclerosis; NPC: Neural
progenitor cell; PBS: Phosphate-buffered saline; PSA-NCAM: Polysialylated
neuronal cell adhesion molecule; RMS: Rostral migratory stream; SOX2:
Sex-determining region Y-box 2; SVZ: Subventricular zone
Acknowledgements
The authors thank Ms. Kimiko Takaishi for assistance with the animal surgery
and preparation of brain sections.
Funding
This work was partly supported by Grant-in-Aid for Young Scientists (B), JSPS
KAKENHI.
Availability of data and materials
Original data will be available upon request.
Authors’ contributions
FW, NB, YS, and TY designed the research study. FW and NB performed the
research and the statistical analyses. FW and NB wrote the manuscript. NB, YS,
TY, ET, and MT revised the manuscript for publication. MT, NM, and YS
supervised the project. All authors approved the final version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
All authors have contributed to, read, and approved the final manuscript for
submission.
Ethics approval and consent to participate
All animal experiments were performed under an institutionally approved
protocol for the use of animal research at Kochi University (approval number:
J-00002).
Author details
1Center for Innovative and Translational Medicine, Kochi University Medical
School, Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan. 2Institute for
Laboratory Animal Research, Science Research Center, Kochi University
Medical School, Kochi, Japan. 3Department of Obstetrics and Gynecology,
Kochi University Medical School, Kochi, Japan.
Received: 21 October 2016 Revised: 20 December 2016
Accepted: 6 January 2017
References
1. Kadam SD, Mulholland JD, McDonald JW, Comi AM. Poststroke subgranular
and rostral subventricular zone proliferation in a mouse model of neonatal
stroke. J Neurosci Res. 2009;87(12):2653–66.
2. Parent JM. Injury-induced neurogenesis in the adult mammalian brain.
Neuroscientist. 2003;9(4):261–72.
3. Plane JM, Liu R, Wang TW, Silverstein FS, Parent JM. Neonatal hypoxic-
ischemic injury increases forebrain subventricular zone neurogenesis in the
mouse. Neurobiol Dis. 2004;16(3):585–95.
4. Ong J, Plane JM, Parent JM, Silverstein FS. Hypoxic-ischemic injury
stimulates subventricular zone proliferation and neurogenesis in the
neonatal rat. Pediatr Res. 2005;58(3):600–6.
5. Jin K, Wang X, Xie L, Mao XO, Zhu W, Wang Y, Shen J, Mao Y, Banwait S,
Greenberg DA. Evidence for stroke-induced neurogenesis in the human
brain. Proc Natl Acad Sci U S A. 2006;103(35):13198–202.
6. Nakayama D, Matsuyama T, Ishibashi-Ueda H, Nakagomi T, Kasahara Y,
Hirose H, Kikuchi-Taura A, Stern DM, Mori H, Taguchi A. Injury-induced
neural stem/progenitor cells in post-stroke human cerebral cortex. Eur J
Neurosci. 2010;31(1):90–8.
7. Kaneko N, Marín O, Koike M, Hirota Y, Uchiyama Y, Wu JY, Lu Q, Tessier-
Lavigne M, Alvarez-Buylla A, Okano H, Rubenstein JL, Sawamoto K. New
neurons clear the path of astrocytic processes for their rapid migration in
the adult brain. Neuron. 2010;67(2):213–23.
8. García-González D, Clemente D, Coelho M, Esteban PF, Soussi-Yanicostas N,
de Castro F. Dynamic roles of FGF-2 and Anosmin-1 in the migration of
neuronal precursors from the subventricular zone during pre- and postnatal
development. Exp Neurol. 2010;222(2):285–95.
9. Kojima T, Hirota Y, Ema M, Takahashi S, Miyoshi I, Okano H, Sawamoto K.
Subventricular zone-derived neural progenitor cells migrate along a blood
vessel scaffold toward the post-stroke striatum. Stem Cells. 2010;28:545–54.
10. Osman AM, Porritt MJ, Nilsson M, Kuhn HG. Long-term stimulation of neural
progenitor cell migration after cortical ischemia in mice. Stroke. 2011;42:3559–65.
11. Liu XS, Zhang ZG, Zhang RL, Gregg SR, Wang L, Yier T, Chopp M.
Chemokine ligand 2 (CCL2) induces migration and differentiation of
subventricular zone cells after stroke. J Neurosci Res. 2007;85(10):2120–5.
12. Wang F, Shen Y, Tsuru E, Yamashita T, Baba N, Tsuda M, Maeda N, Sagara Y.
Syngeneic transplantation of newborn splenocytes in a murine model of
neonatal ischemia-reperfusion brain injury. J Matern Fetal Neonatal Med.
2015;28(7):842–7.
13. Sallusto F, Baggiolini M. Chemokines and leukocyte traffic. Nat Immunol.
2008;9(9):949–52.
14. Parent JM, Vexler ZS, Gong C, Derugin N, Ferriero DM. Rat forebrain
neurogenesis and striatal neuron replacement after focal stroke. Ann Neurol.
2002;52(6):802–13.
15. Ohab JJ, Fleming S, Blesch A, Carmichael ST. A neurovascular niche for
neurogenesis after stroke. J Neurosci. 2006;26(50):13007–16.
16. Yamashita T, Ninomiya M, Hernández Acosta P, García-Verdugo JM,
Sunabori T, Sakaguchi M, Adachi K, Kojima T, Hirota Y, Kawase T, Araki N,
Abe K, Okano H, Sawamoto K. Subventricular zone-derived neuroblasts
migrate and differentiate into mature neurons in the post-stroke adult
striatum. J Neurosci. 2006;26(24):6627–36.
17. Thored P, Arvidsson A, Cacci E, Ahlenius H, Kallur T, Darsalia V, Ekdahl CT,
Kokaia Z, Lindvall O. Persistent production of neurons from adult brain stem
cells during recovery after stroke. Stem Cells. 2006;24(3):739–47.
18. Studer L, Csete M, Lee SH, Kabbani N, Walikonis J, Wold B, McKay R.
Enhanced proliferation, survival, and dopaminergic differentiation of CNS
precursors in lowered oxygen. J Neurosci. 2000;20(19):7377–83.
19. Kalluri HS, Eickstaedt J, Dempsey RJ. Oxygen glucose deprivation inhibits
the growth and ERK phosphorylation of neural progenitor cells in vitro.
Neurosci Lett. 2007;426(3):145–8.
20. Cartier L, Hartley O, Dubois-Dauphin M, Krause KH. Chemokine receptors in
the central nervous system: role in brain inflammation and
neurodegenerative diseases. Brain Res Brain Res Rev. 2005;48(1):16–42.
21. Tran PB, Ren D, Veldhouse TJ, Miller RJ. Chemokine receptors are expressed
widely by embryonic and adult neural progenitor cells. J Neurosci Res.
2004;76(1):20–34.
22. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson
RT, Springer TA. Impaired B-lymphopoiesis, myelopoiesis, and derailed
cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl
Acad Sci U S A. 1998;95(16):9448–53.
23. Lu M, Grove EA, Miller RJ. Abnormal development of the hippocampal
dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl
Acad Sci U S A. 2002;99(10):7090–5.
24. Robin AM, Zhang ZG, Wang L, Zhang RL, Katakowski M, Zhang L, Wang Y,
Zhang C, Chopp M. Stromal cell-derived factor 1alpha mediates neural
progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow
Metab. 2006;26(1):125–34.
25. Peng H, Huang Y, Rose J, Erichsen D, Herek S, Fujii N, Tamamura H, Zheng J.
Stromal cell-derived factor 1-mediated CXCR4 signaling in rat and human
cortical neural progenitor cells. J Neurosci Res. 2004;76(1):35–50.
Wang et al. Stem Cell Research & Therapy  (2017) 8:26 Page 10 of 11
26. Gordon RJ, McGregor AL, Connor B. Chemokines direct neural progenitor cell
migration following striatal cell loss. Mol Cell Neurosci. 2009;41(2):219–32.
27. Lum M, Croze E, Wagner C, McLenachan S, Mitrovic B, Turnley AM.
Inhibition of neurosphere proliferation by IFNgamma but not IFNbeta is
coupled to neuronal differentiation. J Neuroimmunol. 2009;206(1-2):32–8.
28. Im SH, Yu JH, Park ES, Lee JE, Kim HO, Park KI, Kim GW, Park CI, Cho SR.
Induction of striatal neurogenesis enhances functional recovery in an adult
animal model of neonatal hypoxic-ischemic brain injury. Neuroscience.
2010;169(1):259–68.
29. Millard CJ, Ludeman JP, Canals M, Bridgford JL, Hinds MG, Clayton DJ,
Christopoulos A, Payne RJ, Stone MJ. Structural basis of receptor
sulfotyrosine recognition by a CC chemokine: the N-terminal region of
CCR3 bound to CCL11/eotaxin-1. Structure. 2014;22(11):1571–81.
30. Fryer AD, Stein LH, Nie Z, Curtis DE, Evans CM, Hodgson ST, Jose PJ,
Belmonte KE, Fitch E, Jacoby DB. Neuronal eotaxin and the effects of CCR3
antagonist on airway hyperreactivity and M2 receptor dysfunction. J Clin
Invest. 2006;116(1):228–36.
31. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N,
Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Després S, Aigner L, Li
G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray
T. The ageing systemic milieu negatively regulates neurogenesis and
cognitive function. Nature. 2011;477(7362):90–4.
32. Lezi E, Burns JM, Swerdlow RH. Effect of high-intensity exercise on aged
mouse brain mitochondria, neurogenesis, and inflammation. Neurobiol
Aging. 2014;35(11):2574–83.
33. de Miranda AS, Brant F, Campos AC, Vieira LB, Rocha NP, Cisalpino D, Binda
NS, Rodrigues DH, Ransohoff RM, Machado FS, Rachid MA, Teixeira AL.
Evidence for the contribution of adult neurogenesis and hippocampal cell
death in experimental cerebral malaria cognitive outcome. Neuroscience.
2015;284:920–33.
34. Parajuli B, Horiuchi H, Mizuno T, Takeuchi H, Suzumura A. CCL11 enhances
excitotoxic neuronal death by producing reactive oxygen species in
microglia. Glia. 2015;63(12):2274–84.
35. Erickson MA, Morofuji Y, Owen JB, Banks WA. Rapid transport of CCL11
across the blood-brain barrier: regional variation and importance of blood
cells. J Pharmacol Exp Ther. 2014;349(3):497–507.
36. Adzemovic MZ, Öckinger J, Zeitelhofer M, Hochmeister S, Beyeen AD,
Paulson A, Gillett A, Thessen Hedreul M, Covacu R, Lassmann H, Olsson T,
Jagodic M. Expression of Ccl11 associates with immune response
modulation and protection against neuroinflammation in rats. PLoS One.
2012;7(7), e39794.
37. Kodali RB, Kim WJ, Galaria II, Miller C, Schecter AD, Lira SA, Taubman MB.
CCL11 (Eotaxin) induces CCR3-dependent smooth muscle cell migration.
Arterioscler Thromb Vasc Biol. 2004;24(7):1211–6.
38. Maysami S, Nguyen D, Zobel F, Heine S, Höpfner M. Oligodendrocyte
precursor cells express a functional chemokine receptor CCR3: implications
for myelination. Stangel M J Neuroimmunol. 2006;178(1-2):17–23.
39. Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, Pham-Dinh D,
Levine J. The response of NG2-expressing oligodendrocyte progenitors to
demyelination in MOG-EAE and MS. J Neurocytol. 2002;31(6-7):523–36.
40. Bozzali M, Wrabetz L. Axonal signals and oligodendrocyte differentiation.
Neurochem Res. 2004;29(5):979–88.
41. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57:791–804.
42. Furukawa T, Matsui N, Fujita K, Nodera H, Shimizu F, Miyamoto K, Takahashi
Y, Kanda T, Kusunoki S, Izumi Y, Kaji R. CSF cytokine profile distinguishes
multifocal motor neuropathy from progressive muscular atrophy. Neurol
Neuroimmunol Neuroinflamm. 2015;2(5), e138.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Wang et al. Stem Cell Research & Therapy  (2017) 8:26 Page 11 of 11
